The global tissue diagnostics market size was valued at $4.2 billion in 2019 and is expected to record a 5% CAGR during the analysis period. Tissue diagnosis is one of the gold standards for cancer diagnosis because these techniques capture the biological context of a tumor. With increasing cancer incidence, the tissue diagnostics market has witnessed high demand along with profitable growth opportunities in the near future.
A full report of Tissue Diagnostics Market available at https://www.orionmarketreports.com/tissue-diagnostics-market/10881/
Tissue Diagnostics Market Segmentations
By Product
• Instrumentsac
• Reagents & Consumables
By Technology
• Immunohistochemistry
• In-Situ Hybridization
• Digital Pathology & Workflow Management
• Others
By Application
• Breast Cancer
• Prostate Cancer
• Gastric Cancer
• Other Cancers
Company Profiles:
• Abbott Laboratories
• Agilent
• Merck
• Roche
• Danaher
• Thermo Fisher Scientific
• Sigma Aldrich
• BioGenex Laboratories
• Cancer Genetics
• Definiens
• Genomic Health
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)